CHM Ann: Chimeric's Phase 1B glioblastoma trial presented at ASCO23 - 6th Jun 2023, 11:03am

annb0t

annb0t

Top 20
CHM Ann: Chimeric's Phase 1B glioblastoma trial presented at ASCO23
Price Sensitive: N
Date: 6th Jun 2023, 11:03am

>>> Read announcement: Google: CHM Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
CHM Ann: Chimeric to receive A$4.4 million introduction fee - 16th Aug 2023, 12:33pm
Replies
0
Views
86
annb0t
annb0t
annb0t
CHM Ann: Chimeric to present at virtual healthcare conference - 15th Mar 2023, 9:40am
Replies
0
Views
91
annb0t
annb0t
annb0t
CHM Ann: CHIMERIC RECEIVES $3.06M R&D TAX INCENTIVE - 14th Feb 2023, 2:59pm
Replies
0
Views
186
annb0t
annb0t
annb0t
CHM Ann: CHIMERIC PARTNERS WITH BE THE MATCH BIOTHERAPIES - 4th Mar 2022, 1:16pm
Replies
0
Views
267
annb0t
annb0t
annb0t
CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 10:25am
Replies
0
Views
105
annb0t
annb0t
Top Bottom